Jeanelle Sheeder
Concepts (612)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Contraception | 18 | 2023 | 123 | 7.650 |
Why?
| Contraceptive Agents, Female | 23 | 2023 | 65 | 4.270 |
Why?
| Family Planning Services | 11 | 2022 | 70 | 3.740 |
Why?
| Contraceptive Agents | 7 | 2023 | 61 | 3.520 |
Why?
| Contraception Behavior | 18 | 2023 | 84 | 3.480 |
Why?
| Pregnancy in Adolescence | 17 | 2015 | 77 | 3.390 |
Why?
| Desogestrel | 19 | 2023 | 42 | 2.870 |
Why?
| Pregnancy | 73 | 2023 | 5854 | 2.410 |
Why?
| Long-Acting Reversible Contraception | 8 | 2023 | 29 | 2.400 |
Why?
| Abortion, Induced | 12 | 2023 | 73 | 2.150 |
Why?
| Prenatal Care | 9 | 2020 | 261 | 2.110 |
Why?
| Hospitals, Religious | 5 | 2020 | 5 | 1.860 |
Why?
| Counseling | 6 | 2020 | 364 | 1.730 |
Why?
| Drug Implants | 17 | 2023 | 71 | 1.680 |
Why?
| Intrauterine Devices | 7 | 2019 | 25 | 1.680 |
Why?
| Female | 158 | 2023 | 63629 | 1.590 |
Why?
| Gynecology | 10 | 2023 | 190 | 1.540 |
Why?
| Adolescent Behavior | 9 | 2015 | 495 | 1.530 |
Why?
| Postpartum Period | 10 | 2022 | 281 | 1.520 |
Why?
| Adolescent | 82 | 2023 | 18948 | 1.460 |
Why?
| Young Adult | 60 | 2023 | 11094 | 1.420 |
Why?
| Pregnancy Outcome | 8 | 2021 | 364 | 1.290 |
Why?
| Endometrial Neoplasms | 10 | 2022 | 144 | 1.290 |
Why?
| Reproductive Health | 4 | 2023 | 74 | 1.290 |
Why?
| Catholicism | 5 | 2020 | 9 | 1.230 |
Why?
| Humans | 174 | 2023 | 122796 | 1.140 |
Why?
| Colorado | 33 | 2023 | 4325 | 1.100 |
Why?
| Obstetrics | 7 | 2023 | 169 | 1.080 |
Why?
| Contraceptives, Oral, Combined | 2 | 2023 | 16 | 1.070 |
Why?
| Patient Acceptance of Health Care | 3 | 2020 | 707 | 1.020 |
Why?
| Postnatal Care | 3 | 2021 | 73 | 1.000 |
Why?
| Adult | 85 | 2023 | 32385 | 0.980 |
Why?
| Health Knowledge, Attitudes, Practice | 10 | 2020 | 1213 | 0.980 |
Why?
| Enoxaparin | 2 | 2020 | 52 | 0.920 |
Why?
| Sexual Behavior | 7 | 2022 | 470 | 0.910 |
Why?
| Patient Satisfaction | 5 | 2023 | 632 | 0.900 |
Why?
| Pyridones | 2 | 2020 | 120 | 0.880 |
Why?
| Adolescent Health Services | 3 | 2020 | 68 | 0.860 |
Why?
| Religion and Medicine | 3 | 2020 | 29 | 0.850 |
Why?
| Cross-Sectional Studies | 21 | 2023 | 4734 | 0.800 |
Why?
| Levonorgestrel | 4 | 2018 | 31 | 0.770 |
Why?
| Pyrazoles | 2 | 2020 | 366 | 0.750 |
Why?
| Parity | 5 | 2016 | 108 | 0.740 |
Why?
| Pregnant Women | 2 | 2019 | 137 | 0.740 |
Why?
| Group Processes | 2 | 2018 | 57 | 0.740 |
Why?
| Venous Thromboembolism | 2 | 2020 | 239 | 0.730 |
Why?
| Mothers | 5 | 2022 | 728 | 0.730 |
Why?
| Religion and Psychology | 1 | 2019 | 28 | 0.720 |
Why?
| Postoperative Hemorrhage | 1 | 2020 | 89 | 0.710 |
Why?
| Hysterectomy | 6 | 2019 | 119 | 0.710 |
Why?
| Sex Offenses | 1 | 2022 | 145 | 0.690 |
Why?
| Pregnancy Rate | 2 | 2017 | 57 | 0.690 |
Why?
| Surveys and Questionnaires | 22 | 2023 | 4882 | 0.680 |
Why?
| Ovarian Neoplasms | 6 | 2020 | 460 | 0.680 |
Why?
| Rural Health Services | 1 | 2019 | 108 | 0.680 |
Why?
| Patient-Centered Care | 2 | 2021 | 513 | 0.670 |
Why?
| Vulnerable Populations | 1 | 2020 | 152 | 0.660 |
Why?
| Intrauterine Devices, Copper | 5 | 2018 | 8 | 0.650 |
Why?
| Financial Support | 1 | 2018 | 22 | 0.650 |
Why?
| Health Care Sector | 1 | 2018 | 31 | 0.650 |
Why?
| Pregnancy, Unplanned | 3 | 2017 | 34 | 0.640 |
Why?
| Fibrinolytic Agents | 1 | 2020 | 257 | 0.630 |
Why?
| Community Health Services | 1 | 2019 | 216 | 0.630 |
Why?
| Prosthesis Implantation | 2 | 2017 | 148 | 0.610 |
Why?
| Health Services Accessibility | 3 | 2022 | 813 | 0.600 |
Why?
| Luteal Phase | 1 | 2017 | 45 | 0.590 |
Why?
| Intrauterine Devices, Medicated | 6 | 2017 | 25 | 0.580 |
Why?
| Infant, Low Birth Weight | 2 | 2015 | 130 | 0.580 |
Why?
| Retrospective Studies | 32 | 2023 | 13433 | 0.570 |
Why?
| Parenting | 1 | 2020 | 267 | 0.570 |
Why?
| Lacerations | 3 | 2022 | 28 | 0.560 |
Why?
| Delivery of Health Care | 2 | 2023 | 915 | 0.560 |
Why?
| Interprofessional Relations | 1 | 2018 | 271 | 0.550 |
Why?
| Depression, Postpartum | 3 | 2020 | 103 | 0.540 |
Why?
| Ambulatory Care Facilities | 4 | 2019 | 244 | 0.540 |
Why?
| Group Structure | 1 | 2015 | 1 | 0.530 |
Why?
| Genital Neoplasms, Female | 4 | 2020 | 74 | 0.530 |
Why?
| Health Personnel | 1 | 2021 | 603 | 0.530 |
Why?
| Guatemala | 3 | 2021 | 311 | 0.520 |
Why?
| Perimenopause | 1 | 2015 | 60 | 0.520 |
Why?
| Carcinoma, Endometrioid | 3 | 2022 | 47 | 0.520 |
Why?
| Risk | 2 | 2017 | 890 | 0.510 |
Why?
| Multicenter Studies as Topic | 1 | 2015 | 247 | 0.510 |
Why?
| Fertility Preservation | 3 | 2023 | 49 | 0.500 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2019 | 1260 | 0.500 |
Why?
| Uterus | 1 | 2015 | 197 | 0.500 |
Why?
| Safety-net Providers | 1 | 2015 | 106 | 0.480 |
Why?
| Patient Selection | 3 | 2015 | 717 | 0.480 |
Why?
| Intention | 4 | 2018 | 147 | 0.480 |
Why?
| Maternal Age | 3 | 2018 | 124 | 0.470 |
Why?
| Middle Aged | 39 | 2022 | 28563 | 0.450 |
Why?
| Goals | 1 | 2014 | 167 | 0.450 |
Why?
| Primary Health Care | 4 | 2023 | 1625 | 0.440 |
Why?
| Attitude to Health | 3 | 2020 | 417 | 0.440 |
Why?
| Estradiol | 1 | 2015 | 477 | 0.430 |
Why?
| Papillomavirus Vaccines | 1 | 2015 | 221 | 0.430 |
Why?
| Uterine Cervical Neoplasms | 3 | 2021 | 215 | 0.430 |
Why?
| Choice Behavior | 3 | 2019 | 171 | 0.420 |
Why?
| Internship and Residency | 6 | 2023 | 1065 | 0.420 |
Why?
| Postoperative Complications | 9 | 2020 | 2301 | 0.410 |
Why?
| Premature Birth | 1 | 2015 | 304 | 0.400 |
Why?
| Obstetric Labor Complications | 2 | 2022 | 33 | 0.400 |
Why?
| Feasibility Studies | 7 | 2022 | 780 | 0.390 |
Why?
| Mass Screening | 7 | 2023 | 1095 | 0.390 |
Why?
| Magnetoencephalography | 13 | 2000 | 115 | 0.380 |
Why?
| United States | 19 | 2021 | 13272 | 0.370 |
Why?
| Disclosure | 2 | 2022 | 109 | 0.360 |
Why?
| Nurse Midwives | 2 | 2020 | 22 | 0.360 |
Why?
| Functional Laterality | 11 | 2001 | 215 | 0.360 |
Why?
| Socioeconomic Factors | 5 | 2021 | 1158 | 0.360 |
Why?
| Robotic Surgical Procedures | 3 | 2016 | 94 | 0.360 |
Why?
| Health Behavior | 1 | 2015 | 731 | 0.350 |
Why?
| Lymph Nodes | 3 | 2018 | 466 | 0.350 |
Why?
| Birth Intervals | 2 | 2019 | 19 | 0.340 |
Why?
| Chlamydia trachomatis | 2 | 2007 | 52 | 0.340 |
Why?
| Communication | 3 | 2022 | 776 | 0.340 |
Why?
| Condoms | 3 | 2017 | 123 | 0.340 |
Why?
| Life Style | 3 | 2021 | 436 | 0.340 |
Why?
| Evoked Potentials, Auditory | 10 | 2001 | 212 | 0.340 |
Why?
| Intrauterine Device Expulsion | 3 | 2017 | 7 | 0.330 |
Why?
| Infant, Small for Gestational Age | 2 | 2019 | 74 | 0.320 |
Why?
| Patient Participation | 1 | 2012 | 371 | 0.320 |
Why?
| Chlamydia Infections | 2 | 2007 | 85 | 0.320 |
Why?
| Women's Health | 2 | 2020 | 277 | 0.310 |
Why?
| Attitude | 3 | 2019 | 236 | 0.310 |
Why?
| Pregnancy Complications | 4 | 2019 | 462 | 0.300 |
Why?
| Cohort Studies | 11 | 2021 | 5294 | 0.300 |
Why?
| Vaccination | 1 | 2015 | 1241 | 0.300 |
Why?
| Uterine Cervicitis | 1 | 2006 | 6 | 0.290 |
Why?
| Male | 43 | 2022 | 59639 | 0.290 |
Why?
| Organizational Policy | 2 | 2019 | 69 | 0.290 |
Why?
| Time Factors | 11 | 2019 | 6682 | 0.280 |
Why?
| Marijuana Use | 2 | 2019 | 158 | 0.280 |
Why?
| Age Factors | 8 | 2016 | 3114 | 0.270 |
Why?
| Prospective Studies | 14 | 2022 | 6704 | 0.270 |
Why?
| Perineum | 3 | 2022 | 29 | 0.270 |
Why?
| Depression | 4 | 2023 | 1190 | 0.270 |
Why?
| Aged, 80 and over | 11 | 2021 | 6845 | 0.270 |
Why?
| Aged | 18 | 2021 | 20495 | 0.270 |
Why?
| Gelatin | 2 | 2016 | 36 | 0.270 |
Why?
| Pregnancy Trimester, First | 4 | 2023 | 128 | 0.260 |
Why?
| Clinical Competence | 3 | 2018 | 973 | 0.260 |
Why?
| Fetal Death | 2 | 2016 | 54 | 0.260 |
Why?
| Electronics, Medical | 1 | 2004 | 13 | 0.260 |
Why?
| Laparotomy | 2 | 2015 | 109 | 0.260 |
Why?
| Weight Gain | 6 | 2021 | 511 | 0.250 |
Why?
| Thrombin | 2 | 2016 | 140 | 0.250 |
Why?
| Database Management Systems | 1 | 2004 | 57 | 0.250 |
Why?
| Telemedicine | 2 | 2023 | 691 | 0.240 |
Why?
| Pregnancy Trimester, Second | 4 | 2018 | 74 | 0.240 |
Why?
| Aromatherapy | 1 | 2023 | 4 | 0.240 |
Why?
| Fellowships and Scholarships | 2 | 2018 | 255 | 0.240 |
Why?
| Social Support | 2 | 2020 | 547 | 0.240 |
Why?
| Contraceptive Devices | 1 | 2023 | 1 | 0.240 |
Why?
| Pain, Procedural | 1 | 2023 | 12 | 0.240 |
Why?
| Ethinyl Estradiol | 1 | 2023 | 17 | 0.230 |
Why?
| Birth Weight | 1 | 2006 | 473 | 0.230 |
Why?
| Child | 14 | 2023 | 19561 | 0.230 |
Why?
| Cost-Benefit Analysis | 3 | 2020 | 573 | 0.230 |
Why?
| Patient Health Questionnaire | 1 | 2023 | 21 | 0.230 |
Why?
| Decision Making | 4 | 2016 | 840 | 0.230 |
Why?
| Fertility | 3 | 2023 | 140 | 0.230 |
Why?
| Abortion, Spontaneous | 1 | 2023 | 95 | 0.220 |
Why?
| House Calls | 2 | 2019 | 144 | 0.220 |
Why?
| Leuprolide | 1 | 2022 | 20 | 0.220 |
Why?
| Patient Preference | 2 | 2015 | 170 | 0.220 |
Why?
| Semen | 1 | 2022 | 25 | 0.220 |
Why?
| Pain | 2 | 2018 | 746 | 0.220 |
Why?
| Attitude of Health Personnel | 2 | 2020 | 1012 | 0.220 |
Why?
| Pregnancy Tests | 2 | 2017 | 7 | 0.210 |
Why?
| Gestational Age | 4 | 2021 | 787 | 0.210 |
Why?
| Fetal Membranes, Premature Rupture | 1 | 2021 | 40 | 0.200 |
Why?
| Treatment Adherence and Compliance | 1 | 2021 | 21 | 0.200 |
Why?
| Chorioamnionitis | 1 | 2021 | 40 | 0.200 |
Why?
| Decision Support Techniques | 2 | 2020 | 392 | 0.200 |
Why?
| Students, Medical | 2 | 2016 | 328 | 0.200 |
Why?
| beta Catenin | 2 | 2022 | 223 | 0.200 |
Why?
| Self Report | 3 | 2021 | 730 | 0.190 |
Why?
| Maternal-Child Health Services | 1 | 2020 | 9 | 0.190 |
Why?
| Lymph Node Excision | 3 | 2018 | 161 | 0.190 |
Why?
| Parturition | 2 | 2019 | 58 | 0.190 |
Why?
| Accelerometry | 1 | 2021 | 83 | 0.190 |
Why?
| Evoked Potentials, Somatosensory | 2 | 1999 | 33 | 0.190 |
Why?
| Outpatients | 3 | 2023 | 336 | 0.190 |
Why?
| Magnetics | 2 | 1999 | 38 | 0.190 |
Why?
| Quality-Adjusted Life Years | 1 | 2020 | 125 | 0.180 |
Why?
| Patient Education as Topic | 3 | 2019 | 717 | 0.180 |
Why?
| Health Facilities | 1 | 2020 | 78 | 0.180 |
Why?
| Pharmacogenetics | 1 | 2021 | 151 | 0.180 |
Why?
| Transgender Persons | 1 | 2022 | 134 | 0.180 |
Why?
| Uterine Hemorrhage | 2 | 2021 | 36 | 0.180 |
Why?
| Home Health Nursing | 1 | 2019 | 10 | 0.180 |
Why?
| Menstruation Disturbances | 1 | 2019 | 12 | 0.180 |
Why?
| Medical Oncology | 2 | 2019 | 231 | 0.180 |
Why?
| Ambulatory Surgical Procedures | 2 | 2017 | 53 | 0.180 |
Why?
| Factor Analysis, Statistical | 1 | 2020 | 283 | 0.180 |
Why?
| Hysterectomy, Vaginal | 1 | 2019 | 7 | 0.180 |
Why?
| Cytochrome P450 Family 3 | 1 | 2019 | 2 | 0.180 |
Why?
| Double-Blind Method | 5 | 2018 | 1711 | 0.180 |
Why?
| Cues | 1 | 2022 | 310 | 0.180 |
Why?
| Candidiasis, Vulvovaginal | 1 | 2019 | 6 | 0.180 |
Why?
| Neoplasm Staging | 6 | 2020 | 1234 | 0.180 |
Why?
| Cancer Pain | 1 | 2019 | 20 | 0.170 |
Why?
| Vaginosis, Bacterial | 1 | 2019 | 14 | 0.170 |
Why?
| Insulin Resistance | 2 | 2008 | 1192 | 0.170 |
Why?
| Obesity | 5 | 2016 | 2786 | 0.170 |
Why?
| Live Birth | 1 | 2019 | 50 | 0.170 |
Why?
| Clothing | 1 | 2019 | 25 | 0.170 |
Why?
| Anesthesia, Inhalation | 1 | 2018 | 6 | 0.170 |
Why?
| Nitrous Oxide | 1 | 2018 | 12 | 0.170 |
Why?
| Hygiene | 1 | 2019 | 35 | 0.170 |
Why?
| Anesthetics, Inhalation | 1 | 2018 | 14 | 0.170 |
Why?
| Treatment Outcome | 10 | 2020 | 9692 | 0.170 |
Why?
| Anesthesia, Intravenous | 1 | 2018 | 12 | 0.170 |
Why?
| Databases, Factual | 3 | 2021 | 1287 | 0.170 |
Why?
| Physician Assistants | 1 | 2020 | 75 | 0.170 |
Why?
| Organ Transplantation | 1 | 2021 | 165 | 0.170 |
Why?
| Anesthetics, Intravenous | 1 | 2018 | 35 | 0.170 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 1402 | 0.170 |
Why?
| Models, Anatomic | 1 | 2019 | 94 | 0.160 |
Why?
| Nurse Practitioners | 1 | 2020 | 112 | 0.160 |
Why?
| Genitalia, Female | 1 | 2018 | 40 | 0.160 |
Why?
| Ovariectomy | 2 | 2015 | 125 | 0.160 |
Why?
| Databases as Topic | 2 | 2008 | 79 | 0.160 |
Why?
| Hemostasis, Surgical | 2 | 2016 | 24 | 0.160 |
Why?
| Pilot Projects | 3 | 2021 | 1477 | 0.160 |
Why?
| Progesterone | 1 | 2019 | 243 | 0.160 |
Why?
| Oncologists | 1 | 2018 | 31 | 0.160 |
Why?
| Adenocarcinoma | 2 | 2015 | 837 | 0.160 |
Why?
| Commerce | 1 | 2018 | 58 | 0.160 |
Why?
| Off-Label Use | 1 | 2018 | 50 | 0.160 |
Why?
| Culture | 1 | 2019 | 129 | 0.160 |
Why?
| Psychometrics | 4 | 2009 | 672 | 0.160 |
Why?
| Risk-Taking | 2 | 2019 | 334 | 0.160 |
Why?
| Sterilization, Reproductive | 1 | 2017 | 4 | 0.150 |
Why?
| Hysteroscopy | 1 | 2017 | 8 | 0.150 |
Why?
| Urinary Tract Infections | 1 | 2019 | 143 | 0.150 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2018 | 116 | 0.150 |
Why?
| Demyelinating Diseases | 1 | 1998 | 79 | 0.150 |
Why?
| Adenocarcinoma, Mucinous | 1 | 2018 | 64 | 0.150 |
Why?
| Bipolar Disorder | 1 | 1999 | 207 | 0.150 |
Why?
| Quality of Health Care | 2 | 2021 | 631 | 0.150 |
Why?
| Body Mass Index | 4 | 2019 | 2144 | 0.150 |
Why?
| Family | 1 | 2021 | 595 | 0.150 |
Why?
| Infant, Newborn | 6 | 2021 | 5430 | 0.150 |
Why?
| Delivery, Obstetric | 4 | 2022 | 134 | 0.150 |
Why?
| Salpingectomy | 2 | 2015 | 13 | 0.150 |
Why?
| Surgeons | 2 | 2018 | 245 | 0.150 |
Why?
| Sexual Dysfunctions, Psychological | 1 | 2017 | 31 | 0.150 |
Why?
| Professional-Patient Relations | 1 | 2018 | 146 | 0.150 |
Why?
| Abortion, Therapeutic | 1 | 2016 | 5 | 0.150 |
Why?
| Incidence | 5 | 2019 | 2527 | 0.150 |
Why?
| Dilatation and Curettage | 1 | 2016 | 10 | 0.150 |
Why?
| Pelvic Infection | 1 | 2016 | 4 | 0.140 |
Why?
| Surgical Wound Infection | 1 | 2019 | 251 | 0.140 |
Why?
| Minority Groups | 1 | 2018 | 242 | 0.140 |
Why?
| Ambulatory Care | 1 | 2020 | 497 | 0.140 |
Why?
| Brain Diseases | 1 | 1998 | 141 | 0.140 |
Why?
| Weight Reduction Programs | 1 | 2017 | 95 | 0.140 |
Why?
| Sexual Dysfunction, Physiological | 1 | 2017 | 60 | 0.140 |
Why?
| Follow-Up Studies | 8 | 2019 | 4768 | 0.140 |
Why?
| Magnetic Resonance Imaging | 7 | 2001 | 3264 | 0.140 |
Why?
| Infant | 3 | 2023 | 8523 | 0.140 |
Why?
| Tissue Adhesives | 1 | 2016 | 18 | 0.140 |
Why?
| Medical Marijuana | 1 | 2018 | 103 | 0.140 |
Why?
| Conflict of Interest | 1 | 2018 | 138 | 0.140 |
Why?
| Polymorphism, Genetic | 1 | 2019 | 666 | 0.140 |
Why?
| Contraception, Postcoital | 1 | 2016 | 6 | 0.140 |
Why?
| Ultrasonography | 2 | 2019 | 740 | 0.140 |
Why?
| Medroxyprogesterone Acetate | 1 | 2015 | 30 | 0.140 |
Why?
| Pregnancy, Unwanted | 1 | 2015 | 13 | 0.140 |
Why?
| Cerebral Cortex | 1 | 1999 | 430 | 0.140 |
Why?
| Healthcare Disparities | 1 | 2021 | 494 | 0.140 |
Why?
| Risk Reduction Behavior | 2 | 2014 | 205 | 0.140 |
Why?
| Patient Compliance | 2 | 2012 | 561 | 0.130 |
Why?
| Administration, Cutaneous | 1 | 2015 | 126 | 0.130 |
Why?
| Anticoagulants | 1 | 2020 | 589 | 0.130 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 1998 | 513 | 0.130 |
Why?
| Placebos | 1 | 2015 | 204 | 0.130 |
Why?
| Internet | 2 | 2019 | 686 | 0.130 |
Why?
| Advanced Practice Nursing | 1 | 2015 | 20 | 0.130 |
Why?
| Hot Flashes | 1 | 2015 | 73 | 0.130 |
Why?
| Contraceptives, Oral | 1 | 2015 | 26 | 0.130 |
Why?
| Interpersonal Relations | 2 | 2017 | 351 | 0.130 |
Why?
| Curriculum | 3 | 2018 | 925 | 0.130 |
Why?
| Papillomaviridae | 1 | 2015 | 102 | 0.130 |
Why?
| Risk Factors | 10 | 2022 | 9381 | 0.130 |
Why?
| Radiography, Thoracic | 1 | 2016 | 168 | 0.130 |
Why?
| Physician-Patient Relations | 2 | 2019 | 509 | 0.130 |
Why?
| Antineoplastic Agents, Hormonal | 1 | 2015 | 143 | 0.130 |
Why?
| Delayed-Action Preparations | 1 | 2015 | 162 | 0.130 |
Why?
| Pandemics | 1 | 2023 | 1401 | 0.130 |
Why?
| Abdominal Abscess | 1 | 2014 | 27 | 0.130 |
Why?
| Prediabetic State | 1 | 2017 | 236 | 0.120 |
Why?
| Immunization Schedule | 1 | 2015 | 187 | 0.120 |
Why?
| Neoplasm Grading | 3 | 2022 | 265 | 0.120 |
Why?
| Glycoproteins | 1 | 2015 | 323 | 0.120 |
Why?
| Endometrium | 1 | 2014 | 61 | 0.120 |
Why?
| Fatigue | 1 | 2015 | 311 | 0.120 |
Why?
| Digoxin | 1 | 2013 | 29 | 0.120 |
Why?
| Genetic Variation | 1 | 2019 | 952 | 0.120 |
Why?
| Peer Group | 1 | 2015 | 208 | 0.120 |
Why?
| Neoplasm Recurrence, Local | 1 | 2019 | 903 | 0.120 |
Why?
| Otolaryngology | 1 | 2015 | 87 | 0.120 |
Why?
| Fallopian Tube Neoplasms | 1 | 2013 | 15 | 0.110 |
Why?
| Pelvic Neoplasms | 1 | 2013 | 20 | 0.110 |
Why?
| Logistic Models | 5 | 2019 | 1995 | 0.110 |
Why?
| Motivational Interviewing | 1 | 2014 | 87 | 0.110 |
Why?
| Overweight | 1 | 2017 | 516 | 0.110 |
Why?
| Brain | 8 | 2001 | 2540 | 0.110 |
Why?
| Umbilical Cord | 1 | 2013 | 82 | 0.110 |
Why?
| Antigens, CD | 1 | 2015 | 506 | 0.110 |
Why?
| Schizophrenia | 4 | 2000 | 544 | 0.110 |
Why?
| Robotics | 1 | 2014 | 87 | 0.110 |
Why?
| Cystadenocarcinoma, Serous | 1 | 2013 | 54 | 0.110 |
Why?
| Opioid-Related Disorders | 1 | 2019 | 412 | 0.110 |
Why?
| Exercise | 2 | 2021 | 1743 | 0.110 |
Why?
| Neoplastic Stem Cells | 1 | 2015 | 340 | 0.110 |
Why?
| Papillomavirus Infections | 1 | 2015 | 267 | 0.100 |
Why?
| Analgesics, Opioid | 1 | 2019 | 785 | 0.100 |
Why?
| School Health Services | 1 | 2014 | 207 | 0.100 |
Why?
| Hemorrhage | 1 | 2016 | 663 | 0.100 |
Why?
| Rural Population | 3 | 2022 | 482 | 0.100 |
Why?
| Practice Patterns, Physicians' | 1 | 2020 | 1267 | 0.100 |
Why?
| Diabetes Mellitus, Type 2 | 2 | 2017 | 2221 | 0.100 |
Why?
| Abortion Applicants | 1 | 2010 | 2 | 0.100 |
Why?
| Guideline Adherence | 2 | 2021 | 560 | 0.100 |
Why?
| Glucose Tolerance Test | 2 | 2013 | 370 | 0.100 |
Why?
| Education, Medical, Graduate | 1 | 2015 | 432 | 0.100 |
Why?
| Domestic Violence | 1 | 2010 | 46 | 0.100 |
Why?
| Blood Loss, Surgical | 3 | 2016 | 89 | 0.100 |
Why?
| Odds Ratio | 2 | 2016 | 1043 | 0.090 |
Why?
| Anal Canal | 2 | 2022 | 83 | 0.090 |
Why?
| Medication Adherence | 1 | 2015 | 575 | 0.090 |
Why?
| Clinical Clerkship | 1 | 2011 | 99 | 0.090 |
Why?
| Health Care Costs | 1 | 2014 | 414 | 0.090 |
Why?
| Sexual Partners | 2 | 2016 | 184 | 0.090 |
Why?
| Pediatric Obesity | 1 | 2017 | 541 | 0.090 |
Why?
| Peptides | 1 | 2015 | 893 | 0.090 |
Why?
| Neoplasm Invasiveness | 3 | 2017 | 472 | 0.090 |
Why?
| Referral and Consultation | 2 | 2018 | 669 | 0.090 |
Why?
| Preoperative Care | 3 | 2017 | 342 | 0.090 |
Why?
| Sleep | 1 | 2015 | 722 | 0.090 |
Why?
| Latin America | 1 | 2009 | 77 | 0.090 |
Why?
| Abortifacient Agents, Nonsteroidal | 1 | 2009 | 21 | 0.090 |
Why?
| Linear Models | 3 | 2019 | 854 | 0.090 |
Why?
| Gynecologic Surgical Procedures | 2 | 2020 | 49 | 0.090 |
Why?
| Risk Assessment | 4 | 2016 | 3213 | 0.090 |
Why?
| Misoprostol | 1 | 2009 | 20 | 0.090 |
Why?
| Research Design | 1 | 2015 | 1002 | 0.090 |
Why?
| Personality Inventory | 1 | 2009 | 137 | 0.080 |
Why?
| Weight Loss | 2 | 2017 | 663 | 0.080 |
Why?
| Interferon-beta | 2 | 2000 | 87 | 0.080 |
Why?
| Medical Records Systems, Computerized | 1 | 2009 | 92 | 0.080 |
Why?
| Case-Control Studies | 5 | 2020 | 3296 | 0.080 |
Why?
| Dominance, Cerebral | 2 | 2000 | 53 | 0.080 |
Why?
| Sex Factors | 6 | 2020 | 1860 | 0.080 |
Why?
| Menarche | 1 | 2008 | 51 | 0.080 |
Why?
| Breast Feeding | 1 | 2012 | 398 | 0.080 |
Why?
| Nausea | 2 | 2019 | 110 | 0.080 |
Why?
| Pediatrics | 1 | 2016 | 1009 | 0.080 |
Why?
| Psychotic Disorders | 2 | 2000 | 154 | 0.080 |
Why?
| Temporal Lobe | 3 | 1997 | 93 | 0.080 |
Why?
| Schizophrenia, Paranoid | 2 | 1997 | 10 | 0.080 |
Why?
| Models, Theoretical | 1 | 2012 | 574 | 0.080 |
Why?
| Smoking | 1 | 2015 | 1556 | 0.080 |
Why?
| Societies, Medical | 3 | 2018 | 741 | 0.070 |
Why?
| Comorbidity | 2 | 2016 | 1600 | 0.070 |
Why?
| Reference Values | 3 | 2018 | 789 | 0.070 |
Why?
| Students, Health Occupations | 1 | 2007 | 23 | 0.070 |
Why?
| Fathers | 1 | 2006 | 47 | 0.070 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2022 | 466 | 0.070 |
Why?
| Healthy Volunteers | 2 | 2019 | 209 | 0.070 |
Why?
| False Positive Reactions | 1 | 2006 | 118 | 0.070 |
Why?
| Science | 1 | 2007 | 53 | 0.070 |
Why?
| Clinical Laboratory Techniques | 1 | 2007 | 93 | 0.070 |
Why?
| Prognosis | 4 | 2018 | 3563 | 0.070 |
Why?
| Length of Stay | 3 | 2015 | 1077 | 0.070 |
Why?
| Auditory Cortex | 2 | 1997 | 41 | 0.070 |
Why?
| Prevalence | 2 | 2017 | 2442 | 0.070 |
Why?
| Maternal Health Services | 1 | 2007 | 86 | 0.070 |
Why?
| Breast Neoplasms | 1 | 1998 | 1994 | 0.070 |
Why?
| Uterine Cervical Diseases | 1 | 2005 | 6 | 0.070 |
Why?
| Urethritis | 1 | 2005 | 5 | 0.070 |
Why?
| Azithromycin | 1 | 2006 | 94 | 0.070 |
Why?
| Self Efficacy | 2 | 2019 | 367 | 0.070 |
Why?
| Fatty Liver | 1 | 2008 | 254 | 0.070 |
Why?
| Teaching | 1 | 2007 | 241 | 0.060 |
Why?
| Metformin | 1 | 2008 | 303 | 0.060 |
Why?
| Biomarkers, Tumor | 2 | 2022 | 1076 | 0.060 |
Why?
| Acanthosis Nigricans | 1 | 2003 | 6 | 0.060 |
Why?
| Metabolic Syndrome | 1 | 2008 | 395 | 0.060 |
Why?
| Hospitals, University | 2 | 2016 | 183 | 0.060 |
Why?
| Combined Modality Therapy | 2 | 2015 | 1174 | 0.060 |
Why?
| Cytochrome P-450 CYP3A Inducers | 1 | 2023 | 5 | 0.060 |
Why?
| Diagnosis, Differential | 2 | 2008 | 1423 | 0.060 |
Why?
| Urban Population | 2 | 2016 | 425 | 0.060 |
Why?
| Ovulation | 1 | 2023 | 41 | 0.060 |
Why?
| Lung Neoplasms | 1 | 2016 | 2216 | 0.060 |
Why?
| Program Evaluation | 2 | 2019 | 880 | 0.060 |
Why?
| Rifampin | 1 | 2023 | 71 | 0.060 |
Why?
| Longitudinal Studies | 3 | 2017 | 2599 | 0.050 |
Why?
| Anxiety | 2 | 2019 | 888 | 0.050 |
Why?
| Neoplasms | 1 | 2016 | 2235 | 0.050 |
Why?
| Episiotomy | 1 | 2022 | 1 | 0.050 |
Why?
| Menstrual Cycle | 1 | 2022 | 115 | 0.050 |
Why?
| Anti-Bacterial Agents | 2 | 2014 | 1562 | 0.050 |
Why?
| Pregnancy, Twin | 1 | 2021 | 22 | 0.050 |
Why?
| Travel | 1 | 2022 | 124 | 0.050 |
Why?
| Pharmacogenomic Variants | 1 | 2021 | 35 | 0.050 |
Why?
| Alpha Rhythm | 1 | 2000 | 6 | 0.050 |
Why?
| Reproduction | 1 | 2022 | 195 | 0.050 |
Why?
| Biomedical Research | 1 | 2007 | 630 | 0.050 |
Why?
| Wrist | 1 | 2021 | 57 | 0.050 |
Why?
| Time-to-Pregnancy | 1 | 2020 | 5 | 0.050 |
Why?
| Clinical Trials, Phase I as Topic | 1 | 2020 | 50 | 0.050 |
Why?
| Coitus | 2 | 2011 | 31 | 0.050 |
Why?
| Hypoglycemic Agents | 1 | 2008 | 1055 | 0.050 |
Why?
| Cytochrome P-450 CYP2C9 | 1 | 2019 | 18 | 0.050 |
Why?
| Mother-Child Relations | 1 | 2021 | 123 | 0.050 |
Why?
| Ethics, Medical | 1 | 2020 | 80 | 0.050 |
Why?
| Refractory Period, Electrophysiological | 1 | 1999 | 5 | 0.050 |
Why?
| Cytochrome P-450 CYP2C19 | 1 | 2019 | 21 | 0.050 |
Why?
| Needs Assessment | 2 | 2015 | 345 | 0.050 |
Why?
| Tissue Donors | 1 | 2022 | 337 | 0.050 |
Why?
| Analysis of Variance | 5 | 2005 | 1329 | 0.050 |
Why?
| Electroencephalography | 2 | 1999 | 408 | 0.050 |
Why?
| Cytoreduction Surgical Procedures | 1 | 2020 | 40 | 0.050 |
Why?
| Poverty | 2 | 2017 | 475 | 0.050 |
Why?
| Mutation | 2 | 2022 | 3493 | 0.040 |
Why?
| Median Nerve | 1 | 1999 | 21 | 0.040 |
Why?
| Reproducibility of Results | 3 | 2023 | 2977 | 0.040 |
Why?
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2000 | 70 | 0.040 |
Why?
| Visible Human Projects | 1 | 2019 | 3 | 0.040 |
Why?
| Ethics, Institutional | 1 | 2019 | 5 | 0.040 |
Why?
| Reproductive Health Services | 1 | 2019 | 8 | 0.040 |
Why?
| Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 27 | 0.040 |
Why?
| Microsatellite Instability | 1 | 2019 | 31 | 0.040 |
Why?
| DNA Polymerase II | 1 | 2019 | 29 | 0.040 |
Why?
| Neural Inhibition | 1 | 2000 | 165 | 0.040 |
Why?
| Genital Diseases, Female | 1 | 2019 | 29 | 0.040 |
Why?
| Testosterone | 1 | 2022 | 353 | 0.040 |
Why?
| Adjuvants, Immunologic | 1 | 2000 | 211 | 0.040 |
Why?
| Operative Time | 1 | 2019 | 117 | 0.040 |
Why?
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 82 | 0.040 |
Why?
| Intention to Treat Analysis | 1 | 2018 | 72 | 0.040 |
Why?
| Biological Variation, Population | 1 | 2018 | 24 | 0.040 |
Why?
| Pituitary Gland | 1 | 1999 | 164 | 0.040 |
Why?
| Morning Sickness | 1 | 2018 | 4 | 0.040 |
Why?
| Midazolam | 1 | 2018 | 51 | 0.040 |
Why?
| Electric Stimulation | 1 | 1999 | 273 | 0.040 |
Why?
| Thalamus | 1 | 1999 | 83 | 0.040 |
Why?
| Memory | 2 | 1999 | 242 | 0.040 |
Why?
| Hippocampus | 2 | 2001 | 747 | 0.040 |
Why?
| Fentanyl | 1 | 2018 | 70 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2023 | 1855 | 0.040 |
Why?
| Psychology, Adolescent | 2 | 2008 | 64 | 0.040 |
Why?
| Patient Care | 1 | 2019 | 117 | 0.040 |
Why?
| Carmustine | 1 | 1998 | 47 | 0.040 |
Why?
| DNA-Binding Proteins | 1 | 2005 | 1384 | 0.040 |
Why?
| Frozen Sections | 1 | 2018 | 24 | 0.040 |
Why?
| Creatine | 1 | 1998 | 56 | 0.040 |
Why?
| PTEN Phosphohydrolase | 1 | 2019 | 149 | 0.040 |
Why?
| Aspartic Acid | 1 | 1998 | 87 | 0.040 |
Why?
| Memory, Short-Term | 1 | 2000 | 250 | 0.040 |
Why?
| Disease-Free Survival | 1 | 2019 | 661 | 0.040 |
Why?
| Neoadjuvant Therapy | 1 | 2020 | 348 | 0.040 |
Why?
| Cyclophosphamide | 1 | 1998 | 223 | 0.040 |
Why?
| Legislation, Drug | 1 | 2018 | 80 | 0.040 |
Why?
| Hysterosalpingography | 1 | 2017 | 6 | 0.040 |
Why?
| Insurance Coverage | 1 | 2019 | 218 | 0.040 |
Why?
| Antineoplastic Agents | 2 | 2020 | 1990 | 0.040 |
Why?
| Sterilization, Tubal | 1 | 2017 | 11 | 0.040 |
Why?
| Transcription Factors | 1 | 2005 | 1616 | 0.040 |
Why?
| Health Surveys | 1 | 2019 | 468 | 0.040 |
Why?
| Survival Analysis | 1 | 2020 | 1325 | 0.040 |
Why?
| Survival Rate | 1 | 2021 | 1810 | 0.040 |
Why?
| Chemotherapy, Adjuvant | 1 | 1998 | 369 | 0.040 |
Why?
| Health Facility Size | 1 | 2016 | 12 | 0.040 |
Why?
| Hospitals, Private | 1 | 2016 | 12 | 0.040 |
Why?
| Cisplatin | 1 | 1998 | 269 | 0.040 |
Why?
| Marijuana Abuse | 1 | 2019 | 209 | 0.040 |
Why?
| AC133 Antigen | 1 | 2015 | 20 | 0.040 |
Why?
| Pain Measurement | 1 | 2018 | 481 | 0.030 |
Why?
| Self Care | 1 | 2019 | 360 | 0.030 |
Why?
| Colony Count, Microbial | 1 | 2016 | 124 | 0.030 |
Why?
| Terminal Care | 1 | 2019 | 186 | 0.030 |
Why?
| Marriage | 1 | 2017 | 112 | 0.030 |
Why?
| Medical Audit | 1 | 2016 | 78 | 0.030 |
Why?
| Hospitals, Teaching | 1 | 2016 | 114 | 0.030 |
Why?
| Patient Simulation | 1 | 2015 | 33 | 0.030 |
Why?
| Stem Cell Transplantation | 1 | 2016 | 155 | 0.030 |
Why?
| Reaction Time | 4 | 2000 | 416 | 0.030 |
Why?
| Radiotherapy | 1 | 2016 | 187 | 0.030 |
Why?
| Brain Injuries | 1 | 2001 | 488 | 0.030 |
Why?
| Indians, North American | 1 | 2021 | 597 | 0.030 |
Why?
| North America | 1 | 2016 | 271 | 0.030 |
Why?
| Ileus | 1 | 2015 | 13 | 0.030 |
Why?
| Cell Count | 1 | 2015 | 319 | 0.030 |
Why?
| Income | 1 | 2016 | 181 | 0.030 |
Why?
| Urinary Retention | 1 | 2015 | 20 | 0.030 |
Why?
| Elective Surgical Procedures | 1 | 2016 | 165 | 0.030 |
Why?
| Competitive Behavior | 1 | 2015 | 40 | 0.030 |
Why?
| Female Urogenital Diseases | 1 | 2014 | 5 | 0.030 |
Why?
| Adolescent Nutritional Physiological Phenomena | 1 | 2014 | 25 | 0.030 |
Why?
| Chi-Square Distribution | 2 | 2006 | 551 | 0.030 |
Why?
| Natural Family Planning Methods | 1 | 2014 | 2 | 0.030 |
Why?
| Laparoscopy | 1 | 2019 | 426 | 0.030 |
Why?
| Peritoneal Cavity | 1 | 2014 | 25 | 0.030 |
Why?
| Memory Disorders | 1 | 1996 | 170 | 0.030 |
Why?
| Morbidity | 1 | 2015 | 309 | 0.030 |
Why?
| Receptors, Androgen | 1 | 2015 | 136 | 0.030 |
Why?
| Intraoperative Complications | 1 | 2015 | 132 | 0.030 |
Why?
| Delivery of Health Care, Integrated | 1 | 2017 | 247 | 0.030 |
Why?
| Blood Volume | 1 | 2014 | 60 | 0.030 |
Why?
| Vagina | 1 | 2016 | 167 | 0.030 |
Why?
| Homosexuality, Male | 1 | 1995 | 176 | 0.030 |
Why?
| Pelvis | 1 | 2015 | 94 | 0.030 |
Why?
| Severity of Illness Index | 2 | 2015 | 2784 | 0.030 |
Why?
| Hemostatics | 1 | 2014 | 50 | 0.030 |
Why?
| Surgical Procedures, Operative | 1 | 2016 | 227 | 0.030 |
Why?
| Disease Progression | 2 | 2017 | 2546 | 0.030 |
Why?
| Personnel Selection | 1 | 2015 | 77 | 0.030 |
Why?
| Insurance, Health | 1 | 2016 | 259 | 0.030 |
Why?
| Acoustic Stimulation | 3 | 2000 | 333 | 0.030 |
Why?
| Drainage | 1 | 2014 | 165 | 0.030 |
Why?
| Administration, Intravaginal | 1 | 2013 | 43 | 0.030 |
Why?
| Insulin | 1 | 2003 | 2180 | 0.030 |
Why?
| Receptors, Progesterone | 1 | 2015 | 326 | 0.030 |
Why?
| Educational Measurement | 1 | 2016 | 298 | 0.030 |
Why?
| Cesarean Section | 1 | 2015 | 184 | 0.030 |
Why?
| Child Development | 1 | 1998 | 449 | 0.030 |
Why?
| Drug Administration Schedule | 1 | 2015 | 757 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2017 | 1531 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 1998 | 1981 | 0.030 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2021 | 2127 | 0.030 |
Why?
| Receptors, Estrogen | 1 | 2015 | 388 | 0.030 |
Why?
| Alcoholism | 1 | 1999 | 725 | 0.030 |
Why?
| Multiple Sclerosis | 1 | 1998 | 395 | 0.030 |
Why?
| Membrane Proteins | 1 | 2019 | 1093 | 0.030 |
Why?
| Patient Readmission | 1 | 2018 | 691 | 0.030 |
Why?
| Biomarkers | 1 | 2023 | 3662 | 0.030 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 1998 | 543 | 0.030 |
Why?
| Perception | 1 | 2015 | 324 | 0.030 |
Why?
| Health Care Surveys | 1 | 2014 | 564 | 0.030 |
Why?
| Text Messaging | 1 | 2014 | 161 | 0.030 |
Why?
| Escherichia coli | 1 | 2016 | 767 | 0.030 |
Why?
| Specialty Boards | 1 | 2011 | 43 | 0.030 |
Why?
| Phenotype | 1 | 1999 | 3070 | 0.020 |
Why?
| Registries | 1 | 2019 | 2020 | 0.020 |
Why?
| Faculty | 1 | 2011 | 133 | 0.020 |
Why?
| Medicaid | 1 | 2014 | 416 | 0.020 |
Why?
| Interferon beta-1a | 2 | 2000 | 12 | 0.020 |
Why?
| Students | 1 | 2014 | 529 | 0.020 |
Why?
| New York City | 1 | 2009 | 78 | 0.020 |
Why?
| Physicians | 1 | 2018 | 824 | 0.020 |
Why?
| Interviews as Topic | 1 | 2011 | 601 | 0.020 |
Why?
| Chronic Disease | 1 | 2015 | 1645 | 0.020 |
Why?
| Urban Health Services | 1 | 2009 | 66 | 0.020 |
Why?
| Quality of Life | 1 | 2020 | 2457 | 0.020 |
Why?
| Gravidity | 1 | 2008 | 8 | 0.020 |
Why?
| Injections, Intramuscular | 2 | 2000 | 127 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2015 | 2904 | 0.020 |
Why?
| Patient Discharge | 1 | 2015 | 842 | 0.020 |
Why?
| Southwestern United States | 1 | 2008 | 92 | 0.020 |
Why?
| Cross-Cultural Comparison | 1 | 2008 | 82 | 0.020 |
Why?
| Aging | 1 | 1998 | 1694 | 0.020 |
Why?
| Quality Improvement | 1 | 2015 | 1004 | 0.020 |
Why?
| Social Perception | 1 | 2008 | 100 | 0.020 |
Why?
| Cholesterol, HDL | 1 | 2008 | 202 | 0.020 |
Why?
| Urine | 1 | 2007 | 65 | 0.020 |
Why?
| Medical Indigency | 1 | 2006 | 10 | 0.020 |
Why?
| Child, Preschool | 1 | 2021 | 9755 | 0.020 |
Why?
| Urinalysis | 1 | 2007 | 66 | 0.020 |
Why?
| Puberty | 1 | 2008 | 149 | 0.020 |
Why?
| Hospitalization | 1 | 2016 | 1914 | 0.020 |
Why?
| Diet | 1 | 2014 | 1168 | 0.020 |
Why?
| National Institutes of Health (U.S.) | 1 | 2007 | 122 | 0.020 |
Why?
| Forecasting | 1 | 2008 | 372 | 0.020 |
Why?
| Education | 1 | 2007 | 110 | 0.020 |
Why?
| Health Services Needs and Demand | 1 | 2008 | 265 | 0.020 |
Why?
| Social Environment | 1 | 2008 | 301 | 0.020 |
Why?
| Research Support as Topic | 1 | 2007 | 122 | 0.020 |
Why?
| Apoptosis | 1 | 2015 | 2532 | 0.020 |
Why?
| Triglycerides | 1 | 2008 | 527 | 0.020 |
Why?
| Universities | 1 | 2007 | 356 | 0.020 |
Why?
| Tomography, X-Ray Computed | 1 | 2014 | 2500 | 0.020 |
Why?
| Attention | 2 | 1999 | 443 | 0.020 |
Why?
| Reagent Kits, Diagnostic | 1 | 2004 | 44 | 0.020 |
Why?
| Sex Characteristics | 2 | 1999 | 690 | 0.020 |
Why?
| Self Concept | 1 | 2005 | 221 | 0.010 |
Why?
| Data Interpretation, Statistical | 1 | 2005 | 345 | 0.010 |
Why?
| Proportional Hazards Models | 1 | 2005 | 1184 | 0.010 |
Why?
| Research | 1 | 2005 | 432 | 0.010 |
Why?
| Image Processing, Computer-Assisted | 2 | 1997 | 739 | 0.010 |
Why?
| Blood Pressure | 1 | 2008 | 1713 | 0.010 |
Why?
| Electromagnetic Fields | 1 | 1999 | 21 | 0.010 |
Why?
| Blood Glucose | 1 | 2008 | 1957 | 0.010 |
Why?
| Schizophrenic Psychology | 1 | 1999 | 119 | 0.010 |
Why?
| Wechsler Scales | 1 | 1998 | 57 | 0.010 |
Why?
| Cognition | 1 | 2005 | 1066 | 0.010 |
Why?
| Gadolinium | 1 | 1998 | 78 | 0.010 |
Why?
| Sound Localization | 1 | 1998 | 64 | 0.010 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 1999 | 229 | 0.010 |
Why?
| Least-Squares Analysis | 1 | 1995 | 74 | 0.010 |
Why?
| Adrenal Cortex Hormones | 1 | 1999 | 515 | 0.010 |
Why?
| Verbal Behavior | 1 | 1995 | 51 | 0.010 |
Why?
| Confidence Intervals | 1 | 1996 | 339 | 0.010 |
Why?
| Space Perception | 1 | 1995 | 67 | 0.010 |
Why?
| Recurrence | 1 | 1998 | 998 | 0.010 |
Why?
| Software | 1 | 1999 | 631 | 0.010 |
Why?
| Cognition Disorders | 1 | 1999 | 547 | 0.010 |
Why?
|
|
Sheeder's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|